Medicine and HealthNature Medicine
Precision-guided treatment in high-risk pediatric cancers
L. M. S. Lau, D. Khuong-quang, et al.
Recent research demonstrated that precision medicine significantly improves outcomes for children with high-risk cancers. In a study involving 384 patients, the ZERO Childhood Cancer Precision Medicine Program achieved a 36% objective response rate and improved 2-year progression-free survival compared with standard care. This exciting breakthrough was made possible by the efforts of authors including Loretta M. S. Lau and Dong-Anh Khuong-Quang.
Related Publications
Explore these studies to deepen your understanding
Adjacent work that informs or extends this paper's methodology and findings.
Medicine and Health
Feasibility of functional precision medicine for guiding treatment of relapsed or refractory pediatric cancers
A. M. A. D. L. Rocha, N. E. Berlow, et al.
Medicine and Health
Molecular profiling of 888 pediatric tumors informs future precision trials and data-sharing initiatives in pediatric cancer
S. J. Forrest, H. Gupta, et al.
Medicine and Health
High-precision all-in-one dual robotic arm strategy in oral implant surgery
G. Tang, S. Liu, et al.
Environmental Studies and Forestry
Changes caused by human activities in the high health-risk hot-dry and hot-wet events in China
H. Yao, L. Zhao, et al.
